Conduit Pharmaceuticals Valuation
| CDT Stock | 1.10 0.02 1.79% |
Today, the firm appears to be overvalued. Conduit Pharmaceuticals shows a prevailing Real Value of USD0.99 per share. The current price of the firm is USD1.1. Our model approximates the value of Conduit Pharmaceuticals from analyzing the firm fundamentals such as Return On Asset of -2.07, shares outstanding of 2.3 M, and Shares Owned By Institutions of 1.02 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Conduit Pharmaceuticals' price fluctuation is abnormally volatile at this time. Calculation of the real value of Conduit Pharmaceuticals is based on 3 months time horizon. Increasing Conduit Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Conduit Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 1.10, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.1 | Real 0.99 | Hype 0.93 |
The intrinsic value of Conduit Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Conduit Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Conduit Pharmaceuticals helps investors to forecast how Conduit stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Conduit Pharmaceuticals more accurately as focusing exclusively on Conduit Pharmaceuticals' fundamentals will not take into account other important factors: Conduit Pharmaceuticals Cash |
|
About Conduit Pharmaceuticals Valuation
The stock valuation mechanism determines Conduit Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Conduit Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Conduit Pharmaceuticals. We calculate exposure to Conduit Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Conduit Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -411.3 K | -431.9 K | |
| Pretax Profit Margin | 0.09 | 0.08 | |
| Operating Profit Margin | 0.10 | 0.10 | |
| Net Profit Margin | 0.08 | 0.07 | |
| Gross Profit Margin | 0.34 | 0.30 |
Conduit Pharmaceuticals Current Valuation Indicators
Conduit Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Conduit Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Conduit Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Conduit Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Conduit Pharmaceuticals' worth.Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.